Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) In-Vitro Cancer Diagnostics Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global In-Vitro Cancer Diagnostics Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Instruments
      • 1.3.3 Reagents and Kits
    • 1.4 Market Segment by Application
      • 1.4.1 Global In-Vitro Cancer Diagnostics Market Share by Application (2019-2025)
      • 1.4.2 Laboratories
      • 1.4.3 Hospitals
      • 1.4.4 Others
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global In-Vitro Cancer Diagnostics Market Size
      • 2.1.1 Global In-Vitro Cancer Diagnostics Revenue 2014-2025
      • 2.1.2 Global In-Vitro Cancer Diagnostics Sales 2014-2025
    • 2.2 In-Vitro Cancer Diagnostics Growth Rate by Regions
      • 2.2.1 Global In-Vitro Cancer Diagnostics Sales by Regions 2014-2019
      • 2.2.2 Global In-Vitro Cancer Diagnostics Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 In-Vitro Cancer Diagnostics Sales by Manufacturers
      • 3.1.1 In-Vitro Cancer Diagnostics Sales by Manufacturers 2014-2019
      • 3.1.2 In-Vitro Cancer Diagnostics Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 In-Vitro Cancer Diagnostics Revenue by Manufacturers (2014-2019)
      • 3.2.2 In-Vitro Cancer Diagnostics Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global In-Vitro Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
    • 3.3 In-Vitro Cancer Diagnostics Price by Manufacturers
    • 3.4 Key Manufacturers In-Vitro Cancer Diagnostics Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into In-Vitro Cancer Diagnostics Market
    • 3.6 Key Manufacturers In-Vitro Cancer Diagnostics Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Instruments Sales and Revenue (2014-2019)
      • 4.1.2 Reagents and Kits Sales and Revenue (2014-2019)
    • 4.2 Global In-Vitro Cancer Diagnostics Sales Market Share by Type
    • 4.3 Global In-Vitro Cancer Diagnostics Revenue Market Share by Type
    • 4.4 In-Vitro Cancer Diagnostics Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global In-Vitro Cancer Diagnostics Sales by Application

    6 United States

    • 6.1 United States In-Vitro Cancer Diagnostics Breakdown Data by Company
    • 6.2 United States In-Vitro Cancer Diagnostics Breakdown Data by Type
    • 6.3 United States In-Vitro Cancer Diagnostics Breakdown Data by Application

    7 European Union

    • 7.1 European Union In-Vitro Cancer Diagnostics Breakdown Data by Company
    • 7.2 European Union In-Vitro Cancer Diagnostics Breakdown Data by Type
    • 7.3 European Union In-Vitro Cancer Diagnostics Breakdown Data by Application

    8 China

    • 8.1 China In-Vitro Cancer Diagnostics Breakdown Data by Company
    • 8.2 China In-Vitro Cancer Diagnostics Breakdown Data by Type
    • 8.3 China In-Vitro Cancer Diagnostics Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World In-Vitro Cancer Diagnostics Breakdown Data by Company
    • 9.2 Rest of World In-Vitro Cancer Diagnostics Breakdown Data by Type
    • 9.3 Rest of World In-Vitro Cancer Diagnostics Breakdown Data by Application
    • 9.4 Rest of World In-Vitro Cancer Diagnostics Breakdown Data by Countries
      • 9.4.1 Rest of World In-Vitro Cancer Diagnostics Sales by Countries
      • 9.4.2 Rest of World In-Vitro Cancer Diagnostics Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 MDx Health Quest Diagnostics
      • 10.1.1 MDx Health Quest Diagnostics Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of In-Vitro Cancer Diagnostics
      • 10.1.4 In-Vitro Cancer Diagnostics Product Introduction
      • 10.1.5 MDx Health Quest Diagnostics Recent Development
    • 10.2 R-Biopharm AG
      • 10.2.1 R-Biopharm AG Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of In-Vitro Cancer Diagnostics
      • 10.2.4 In-Vitro Cancer Diagnostics Product Introduction
      • 10.2.5 R-Biopharm AG Recent Development
    • 10.3 Signature Diagnostics
      • 10.3.1 Signature Diagnostics Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of In-Vitro Cancer Diagnostics
      • 10.3.4 In-Vitro Cancer Diagnostics Product Introduction
      • 10.3.5 Signature Diagnostics Recent Development
    • 10.4 Siemens Healthcare
      • 10.4.1 Siemens Healthcare Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of In-Vitro Cancer Diagnostics
      • 10.4.4 In-Vitro Cancer Diagnostics Product Introduction
      • 10.4.5 Siemens Healthcare Recent Development
    • 10.5 Randox Laboratories
      • 10.5.1 Randox Laboratories Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of In-Vitro Cancer Diagnostics
      • 10.5.4 In-Vitro Cancer Diagnostics Product Introduction
      • 10.5.5 Randox Laboratories Recent Development
    • 10.6 Epigenomics AG
      • 10.6.1 Epigenomics AG Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of In-Vitro Cancer Diagnostics
      • 10.6.4 In-Vitro Cancer Diagnostics Product Introduction
      • 10.6.5 Epigenomics AG Recent Development
    • 10.7 Beckman Coulter
      • 10.7.1 Beckman Coulter Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of In-Vitro Cancer Diagnostics
      • 10.7.4 In-Vitro Cancer Diagnostics Product Introduction
      • 10.7.5 Beckman Coulter Recent Development
    • 10.8 Abbott Laboratories
      • 10.8.1 Abbott Laboratories Company Details
      • 10.8.2 Company Description and Business Overview
      • 10.8.3 Sales, Revenue and Market Share of In-Vitro Cancer Diagnostics
      • 10.8.4 In-Vitro Cancer Diagnostics Product Introduction
      • 10.8.5 Abbott Laboratories Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 In-Vitro Cancer Diagnostics Sales Channels
      • 11.2.2 In-Vitro Cancer Diagnostics Distributors
    • 11.3 In-Vitro Cancer Diagnostics Customers

    12 Market Forecast

    • 12.1 Global In-Vitro Cancer Diagnostics Sales and Revenue Forecast 2019-2025
    • 12.2 Global In-Vitro Cancer Diagnostics Sales Forecast by Type
    • 12.3 Global In-Vitro Cancer Diagnostics Sales Forecast by Application
    • 12.4 In-Vitro Cancer Diagnostics Forecast by Regions
      • 12.4.1 Global In-Vitro Cancer Diagnostics Sales Forecast by Regions 2019-2025
      • 12.4.2 Global In-Vitro Cancer Diagnostics Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      In-vitro cancer diagnostics is a technique in which the reagents and medical devices are employed to examine specimens such as body fluids, tissues, stool, urine, and blood.
      In 2019, the market size of In-Vitro Cancer Diagnostics is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for In-Vitro Cancer Diagnostics.

      This report studies the global market size of In-Vitro Cancer Diagnostics, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the In-Vitro Cancer Diagnostics sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      MDx Health Quest Diagnostics
      R-Biopharm AG
      Signature Diagnostics
      Siemens Healthcare
      Randox Laboratories
      Epigenomics AG
      Beckman Coulter
      Abbott Laboratories

      Market Segment by Product Type
      Instruments
      Reagents and Kits

      Market Segment by Application
      Laboratories
      Hospitals
      Others

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the In-Vitro Cancer Diagnostics status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key In-Vitro Cancer Diagnostics manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of In-Vitro Cancer Diagnostics are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now